July 8 2023,

The Plant Lady

THE BIG IDEA

Hi all,

Yes, WeedWeek is now on Threads at @weedweeknews. I’m not sure if the link works. 

Let’s get to it:

  • Could Cookies THCa gambit pay off?
  • Is a “land shark” coming?

Enjoy,

Alex

Advertise in WeedWeek

Our advertising policy.

*

Send tips, press releases, concerns, feedback and criticism to hello@weedweek.com

*

WeedWeek regularly links to paywalled content.

In the news

EXCLUSIVE: COULD COOKIES' THCA GAMBIT PAY OFF?

Cookies
Posted on Cookies’ LinkedIn

A week ago, the country’s best known cannabis brand launched “Cookies on Demand,” a service that mails branded flower, concentrates and other products to consumers in 14 states. As many WeedWeek readers are aware, there’s no legal way to sell state-legal weed across state lines. So, what’s going on here?

Cookies is selling “hemp THCa flower,” under a controversial interpretation of the 2018 federal Farm Bill, which legalized hemp. In recent years, companies have exploited a loophole in the same law to manufacture Delta-8 THC and other intoxicating compounds from hemp, which, per federal law, isn’t allowed to contain more than 0.3% THC. Selling hemp THCa flower across state lines involves what one lawyer described as a “pinhole,” within that loophole.

But it’s also a fast growing business and Cookies wants in. PLUS: Meet a thriving THCa entrepreneur in San Antonio, Texas…

Read the story

LIFE IS BETTER WITH COLLEAGUES WHO READ WEEDWEEK

FOLLOW WeedWeek‘s new job board and be first to hear about great opportunities at top companies.

 

*

HIRING? Find top prospects in our talent pool! 

TALENTED? Get in front of top companies FREE!

TIME FOR A LAND SHARK?

Cronos, the Canadian operator backed by tobacco giant Altria-group, is exploring a sale. MSO Curaleaf is reportedly interested.
Reuters

Todd Harrison at Cannabis Confidential has a characteristically provocative take: “There are several reasons these discussion make sense (CRON cash balance > market cap/ international assets /biosynthetics /more below) but we have questions:”

  • “Would Cronos shareholders bless a consummation near an all-time low?
  • “Could Curaleaf justify the deal given minimal, if any, overlap/ cost-savings?
  • “And most importantly for prevailing sentiment: where will Altria net out—would this be their entrée or an exit?”

Read the post.

QUICK HITS

Federal:

Business:

State and local:

Health and science:

Crime:

Fun and interesting:

CALIFORNIA HITS

State:

Business:

Local:

Equity:

Company milestones:

R.I.P.

Job moves:

Upcoming:

Ads

Mantis

Was this email forwarded to you?

SIGN UP

View our privacy policy here.